Ibandronate metal complexes: solution behavior and antiparasitic activity

[1]  Ian H. Gilbert,et al.  Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need , 2017, Nature Reviews Microbiology.

[2]  L. Beneš,et al.  Cerium(IV) phenylphosphonates and para-substituted phenylphosphonates: preparation and characterization , 2017, Journal of Inclusion Phenomena and Macrocyclic Chemistry.

[3]  S. Adami,et al.  The use of bisphosphonates in women: when to use and when to stop , 2015, Expert opinion on pharmacotherapy.

[4]  M. Mizuguchi,et al.  Protonation State and Hydration of Bisphosphonate Bound to Farnesyl Pyrophosphate Synthase. , 2015, Journal of medicinal chemistry.

[5]  W. Goldeman,et al.  Synthesis of N-methyl alkylaminomethane-1,1-diphosphonic acids and evaluation of their complex-formation abilities towards copper(II) , 2015 .

[6]  B. Garat,et al.  Effect of the metal ion on the anti T. cruzi activity and mechanism of action of 5-nitrofuryl-containing thiosemicarbazone metal complexes , 2014 .

[7]  S. Strittmatter,et al.  Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks , 2014, Nature Medicine.

[8]  Stephen T. C. Wong,et al.  Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. , 2014, Drug discovery today.

[9]  L. Malpezzi,et al.  Structural and thermal characterization of sodium ibandronate monohydrate , 2012, Journal of Thermal Analysis and Calorimetry.

[10]  R. Faccio,et al.  Bisphosphonate metal complexes as selective inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase. , 2012, Dalton transactions.

[11]  R. Russell,et al.  Bisphosphonates: the first 40 years. , 2011, Bone.

[12]  J. Castiglioni,et al.  Risedronate metal complexes potentially active against Chagas disease. , 2010, Journal of inorganic biochemistry.

[13]  C. Janiak,et al.  Iron, copper and zinc ammonium-1-hydroxyalkylidene-diphosphonates with zero-, one- and two-dimensional covalent metal–ligand structures extended into three-dimensional supramolecular networks by charge-assisted hydrogen-bonding , 2010 .

[14]  Rick L. Tarleton,et al.  In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds , 2010, PLoS neglected tropical diseases.

[15]  L. Tušek-Boz̆ić,et al.  Spectroscopic and DFT study of 3-quinolyl-α-aminophosphonates , 2009 .

[16]  Li‐Min Zheng,et al.  A layered cobalt phosphonate exhibiting ferrimagnetism and slow magnetic relaxation , 2008 .

[17]  R. Docampo,et al.  The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites. , 2008, Current pharmaceutical design.

[18]  Li‐Min Zheng,et al.  Ladder-like metal diphosphonates exhibiting field-induced magnetic transitions , 2007 .

[19]  Li‐Min Zheng,et al.  Layered cobalt(II) and nickel(II) diphosphonates showing canted antiferromagnetism and slow relaxation behavior. , 2007, Inorganic chemistry.

[20]  M. Cassera,et al.  A Solanesyl-diphosphate Synthase Localizes in Glycosomes of Trypanosoma cruzi* , 2006, Journal of Biological Chemistry.

[21]  P. Kafarski,et al.  Coordination abilities of piperyd-1-yl-methane-1,1-diphosphonic acids towards zinc(II), magnesium(II) and calcium(II): potentiometric and NMR studies. , 2006, Journal of inorganic biochemistry.

[22]  Changwen Hu,et al.  Transformation from a low-dimensional framework to a high-dimensional architecture based on different metal ions: syntheses, structures, and photoluminescences. , 2006, Inorganic chemistry.

[23]  S. Knapp,et al.  The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Motevalli,et al.  Structural studies on new metal derivatives of osteoporosis therapeutic aminohydroxyalkylidenebisphosphonic acids with C4 and C6 aminoalkyl chains , 2006 .

[25]  Wolfgang Jahnke,et al.  Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs , 2006, ChemMedChem.

[26]  V. Videnova-Adrabińska,et al.  Supramolecular chemistry and complexation abilities of diphosphonic acids , 2005 .

[27]  N. Redman-Furey,et al.  Structural and analytical characterization of three hydrates and an anhydrate form of risedronate. , 2005, Journal of pharmaceutical sciences.

[28]  Zhong‐Ming Sun,et al.  Synthesis and structural characterization of three new manganese(II) diphosphonates with layered and double-chain architectures , 2005 .

[29]  A. Valavanidis,et al.  Comparative study of the formation of oxidative damage marker 8-hydroxy-2′-deoxyguanosine (8-OHdG) adduct from the nucleoside 2′-deoxyguanosine by transition metals and suspensions of particulate matter in relation to metal content and redox reactivity , 2005, Free radical research.

[30]  E. Oldfield,et al.  Inhibition of isoprene biosynthesis pathway enzymes by phosphonates, bisphosphonates, and diphosphates. , 2004, Journal of medicinal chemistry.

[31]  A. Aboukaïs,et al.  Formation of oligonuclear complexes between copper(II) and 1-hydroxyethane-1,1-diphosphonic acid , 2004 .

[32]  J. Urbina,et al.  Specific chemotherapy of Chagas disease: controversies and advances. , 2003, Trends in parasitology.

[33]  P. Wardman,et al.  Evidence for the Role of a Peroxidase Compound I-type Intermediate in the Oxidation of Glutathione, NADH, Ascorbate, and Dichlorofluorescin by Cytochrome c/H2O2 , 2003, Journal of Biological Chemistry.

[34]  G. Bouet,et al.  A comparison of the acidity and the complexing ability of (o-hydroxyphenyl) bis- and (o-hydroxyphenyl) mono-methylenephosphonic acids towards lanthanide(III) ions. , 2002, Talanta.

[35]  H. Kozłowski,et al.  Bisphosphonate chelating agents. Coordination ability of 1-phenyl-1-hydroxymethylene bisphosphonate towards Cu(2+) ions. , 2002, Journal of inorganic biochemistry.

[36]  P. Kafarski,et al.  Interactions of zinc(II), magnesium(II) and calcium(II) with aminomethane-1,1-diphosphonic acids in aqueous solutions , 2002 .

[37]  E. Oldfield,et al.  Bisphosphonates Are Potent Inhibitors of Trypanosoma cruzi Farnesyl Pyrophosphate Synthase* , 2001, The Journal of Biological Chemistry.

[38]  R. Docampo,et al.  Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites. , 2001, Current drug targets. Infectious disorders.

[39]  P. Gans,et al.  GLEE, a new computer program for glass electrode calibration. , 2000, Talanta.

[40]  E. Oldfield,et al.  Trypanosoma cruzi Contains Major Pyrophosphate Stores, and Its Growth in Vitro and in Vivo Is Blocked by Pyrophosphate Analogs* , 1999, The Journal of Biological Chemistry.

[41]  P. Gans,et al.  Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species , 1999 .

[42]  J. Bollinger,et al.  Divalent cations speciation with three phosphonate ligands in the pH-range of natural waters. , 1997, Talanta.

[43]  P. Gans,et al.  Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs. , 1996, Talanta.

[44]  P. Hermann,et al.  Aminoalkylbis(phosphonates): Their Complexation Properties in Solution and in the Solid State , 2007 .

[45]  H. Rilling.  [16] Eukaryotic prenyltransferases , 1985 .